Twist Bioscience Corporation Logo

Twist Bioscience Corporation (TWST)

NASDAQ

Currency in USD
151.42
+10.62 (+7.54%)

Closed

Aug 25, 2026

Day's Range

141.41
154.96

52 wk Range

23.30
154.96

Overview - TWST - Twist Bioscience Corporation

Key Statistics

Valuation

Enterprise Value

8.77B

P/E (Trailing)

‪-116.47‬

P/E (Forward)

‪-222.31‬

PEG Ratio

‪0.44‬

Price / Sales (TTM)

‪20.44‬

Price / Book

‪19.79‬

EV / EBITDA

‪-76.08‬

Profitability

Gross Margin

‪52.75%‬

Profit Margin

‪-31.66%‬

Operating Margin

‪-30.64%‬

Return on Assets

‪-13.08%‬

Return on Equity

‪-29.59%‬

Ownership

Shares Outstanding

62.67M

Float

61.26M

Short % of Shares Outstanding

‪28.74%‬

Held by Insiders

‪0.99%‬

Held by Institutions

‪115.98%‬

Price stats

Beta

‪2.15‬

50-Day Avg

‪101.30‬

200-Day Avg

‪59.85‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 16, 2025

Screened by Zoya using the AAOIFI methodology.

Peers - TWST - Twist Bioscience Corporation

Peer Comparison

Compared with companies in Diagnostics & Research listed on NASDAQ.

Profile Summary - TWST - Twist Bioscience Corporation

About

Twist Bioscience Corporation is a synthetic biology company that manufactures and sells synthetic DNA-based products through a proprietary semiconductor-based platform. This disruptive technology synthesizes DNA on silicon chips rather than traditional plastic plates, enabling high-quality, high-throughput production…

SectorHealthcare
IndustryDiagnostics & Research
Employees979
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.